BERTOLOTTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.755
AS - Asia 13.091
EU - Europa 12.723
SA - Sud America 1.870
Continente sconosciuto - Info sul continente non disponibili 345
AF - Africa 262
OC - Oceania 33
Totale 60.079
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.034
SG - Singapore 4.152
IT - Italia 3.814
CN - Cina 3.508
GB - Regno Unito 3.166
HK - Hong Kong 1.574
BR - Brasile 1.403
VN - Vietnam 1.232
DE - Germania 1.036
SE - Svezia 957
FI - Finlandia 783
BD - Bangladesh 634
UA - Ucraina 590
FR - Francia 543
TR - Turchia 482
RU - Federazione Russa 464
CA - Canada 435
PL - Polonia 390
KR - Corea 328
IN - India 251
BG - Bulgaria 228
NL - Olanda 220
ID - Indonesia 171
AR - Argentina 169
JP - Giappone 107
IQ - Iraq 104
MX - Messico 96
ES - Italia 89
IE - Irlanda 80
EC - Ecuador 71
PK - Pakistan 63
ZA - Sudafrica 61
BE - Belgio 54
CO - Colombia 54
AE - Emirati Arabi Uniti 53
VE - Venezuela 53
AT - Austria 51
MY - Malesia 51
MA - Marocco 50
CL - Cile 46
PH - Filippine 45
UZ - Uzbekistan 43
TW - Taiwan 42
CR - Costa Rica 40
CH - Svizzera 39
SA - Arabia Saudita 36
CZ - Repubblica Ceca 32
JM - Giamaica 31
IR - Iran 29
AU - Australia 27
LT - Lituania 26
PE - Perù 26
JO - Giordania 25
TH - Thailandia 25
ET - Etiopia 24
EG - Egitto 23
DZ - Algeria 21
PY - Paraguay 21
TT - Trinidad e Tobago 21
HN - Honduras 20
GR - Grecia 19
RO - Romania 19
TN - Tunisia 19
KE - Kenya 16
UY - Uruguay 16
NP - Nepal 15
OM - Oman 15
IL - Israele 13
NI - Nicaragua 13
PT - Portogallo 13
PA - Panama 12
AZ - Azerbaigian 11
BY - Bielorussia 11
GT - Guatemala 11
SI - Slovenia 11
BO - Bolivia 10
MK - Macedonia 9
NG - Nigeria 9
RS - Serbia 9
SV - El Salvador 9
DO - Repubblica Dominicana 8
EU - Europa 8
PR - Porto Rico 8
PS - Palestinian Territory 8
SC - Seychelles 8
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
AL - Albania 7
AM - Armenia 7
BH - Bahrain 7
DK - Danimarca 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
MD - Moldavia 7
EE - Estonia 6
HU - Ungheria 6
KW - Kuwait 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
Totale 59.645
Salva come PNG Salva come JPEG
Città #
Ashburn 4.176
Singapore 2.791
Santa Clara 2.482
Fairfield 2.380
Southend 2.013
Hong Kong 1.550
Woodbridge 1.496
San Jose 1.410
Houston 1.328
Chandler 1.322
Jacksonville 1.046
Hefei 984
Seattle 899
Dearborn 830
Wilmington 827
Ann Arbor 820
Council Bluffs 794
Cambridge 788
Beijing 637
Chicago 587
Helsinki 577
London 577
Nyköping 571
Los Angeles 567
Ho Chi Minh City 404
Modena 387
New York 380
Warsaw 372
Milan 333
Seoul 315
The Dalles 311
San Diego 301
Hanoi 281
Izmir 278
Princeton 244
Sofia 216
São Paulo 209
Salt Lake City 198
Eugene 187
Buffalo 186
Lauterbourg 186
Rome 179
Boardman 168
Shanghai 165
Columbus 160
Toronto 157
Dallas 144
Moscow 143
Munich 131
Bologna 125
Tampa 118
Elk Grove Village 112
Des Moines 110
Jakarta 104
Orem 85
Fremont 83
Phoenix 79
Tokyo 79
Washington 79
Frankfurt am Main 75
Redwood City 75
Guangzhou 71
Dublin 64
Brooklyn 63
Haiphong 62
Montreal 60
Denver 59
Bremen 57
Grafing 57
Naples 57
Atlanta 56
Da Nang 55
Falls Church 54
Sterling 53
Baghdad 49
Florence 49
San Francisco 49
Brussels 44
Parma 44
Turin 44
North Bergen 43
North York 42
Miami 41
Lancaster 40
Turku 40
San Mateo 39
Boston 38
Manchester 38
Nuremberg 38
Amsterdam 37
Mountain View 35
Chennai 34
Kunming 34
Norwalk 34
Tashkent 34
Kent 32
Mexico City 32
Nanjing 32
Padova 32
Charlotte 31
Totale 40.384
Salva come PNG Salva come JPEG
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 1.251
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 742
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 536
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 485
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 475
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 467
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 455
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 447
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 436
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 425
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 424
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 413
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 404
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 399
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 398
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 395
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 395
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 391
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 391
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 391
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 386
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 384
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 381
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 380
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 377
Physical exercise for late life depression: effects on cognition and disability 376
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 372
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 370
La clinica metabolica per il trattamento della lipodistrofia 369
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 368
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 366
Telomere length elongation after weight loss intervention in obese adults 362
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 362
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 360
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 358
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 356
Endocrine and liver interaction: the role of endocrine pathways in NASH 356
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 355
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 354
The relationship between age and fat infiltration in liver and muscle 351
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 349
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 348
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 346
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 345
Nonalcoholic fatty liver disease and aging: epidemiology to management 344
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 343
Analgesic drug taking: Beliefs and behavior among headache patients 341
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 339
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 333
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 331
Anatomia e fisiologia delle vie biliari 328
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 325
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 325
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 321
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 321
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 320
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 319
Risk of birth defects associated with maternal pregestational diabetes. 318
Review article: effect of bile salt pool composition on hepatic and biliary functions 314
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 313
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 313
Disposition of naproxen after oral administration during and between migraine attacks. 311
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 310
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 309
Associated factors to post-operative delirium in patients with hip fractures: an orthogeriatric experience. 309
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 308
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 304
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 302
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 300
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 300
Advances in the comprehension of the pathophysiology of bile secretion 299
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 297
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 295
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 294
Effects of acute changes of bile acid pool composition on biliary lipid secretion 293
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 293
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 292
Bile acid structure and regulation of biliary protein secretion and composition in man 291
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 291
Olanzapine metabolic side effects: a weight gain issue? 290
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 287
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 287
Effect of ursocholic acid on bile lipid secretion and composition 285
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 281
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 280
Case of an old man with aortic dissection type A and enlarging meningioma 279
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 278
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 277
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 277
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 275
Nonalcoholic fatty liver disease induced by leuprorelin acetate 273
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 271
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 271
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 270
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 270
Review article: hyperlipidaemia and cardiovascular risk 269
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 267
Instrumental assessment of balance and gait in depression: A systematic review 267
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 267
Drug-Induced Liver Injury - Types and Phenotypes 266
Totale 35.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.404 0 0 0 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202618.278 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 1.316 931
2026/20275.971 656 1.172 1.654 2.489 0 0 0 0 0 0 0 0
Totale 60.079